Sterling Investment Advisors (Pennsylvania)’s Grace Therapeutics GRCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
2022
Q2
$4K Hold
2022
Q1
$6K Hold
2021
Q4
$6K Hold
2021
Q3
$10K Hold
2021
Q2
$22K Hold
2021
Q1
$24K Hold
2020
Q4
$13K Hold
2020
Q3
$8K Hold
2020
Q2
$18K Hold
2020
Q1
$15K Buy
2019
Q4
$49K Hold
2019
Q3
$38K Buy